Early research (Phase 1)Ended earlyNCT04762602What this trial is testingHMPL-306 in Advanced Solid Tumors With IDH MutationsWho this might be right forIsocitrate Dehydrogenase Gene Mutation Hutchmed 42
Not applicableLooking for participantsNCT04142437What this trial is testingStudy to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the BodyWho this might be right forLocally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion Bayer 150
Very early researchEnded earlyNCT01427322What this trial is testingRandomized RT +/- Lapatinib for Advanced Solid Tumor Cancer Patients Receiving Radiation Therapy for Metastatic DiseaseWho this might be right forEpithelial Cancer Virginia Commonwealth University 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT04699188What this trial is testingStudy of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C MutationWho this might be right forKRAS G12C Mutant Solid TumorsCarcinoma, Non-Small-Cell LungCarcinoma, Colorectal+7 more Novartis Pharmaceuticals 344
Early research (Phase 1)Study completedNCT05639751What this trial is testingPRT3789 Monotherapy and in Combo w/Docetaxel in Participants w/Advanced or Metastatic Solid Tumors w/SMARCA4 MutationWho this might be right forAdvanced Solid TumorMetastatic Solid TumorNon-small Cell Lung Cancers+1 more Prelude Therapeutics Incorporated 135
Early research (Phase 1)Study completedNCT03864042What this trial is testingPharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid TumorsWho this might be right forAdvanced Solid TumorsMetastatic Melanoma Pfizer 56
Testing effectiveness (Phase 2)Looking for participantsNCT07105215What this trial is testingA I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC278 in the Treatment of Solid TumorsWho this might be right forSolid Tumors RemeGen Co., Ltd. 312
Early research (Phase 1)Study completedNCT00098943What this trial is testingNGR-TNF in Treating Patients With Advanced Solid TumorsWho this might be right forColorectal CancerHead and Neck CancerKidney Cancer+1 more European Organisation for Research and Treatment of Cancer - EORTC 70
Testing effectiveness (Phase 2)Ended earlyNCT03875313What this trial is testingStudy of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid TumorsWho this might be right forSolid TumorClear Cell Renal Cell CarcinomaTNBC - Triple-Negative Breast Cancer+4 more Calithera Biosciences, Inc 33
Early research (Phase 1)Study completedNCT05702424What this trial is testingEvaluation of IGM-7354 in Adults With Relapsed and/or Refractory CancerWho this might be right forSolid Tumor IGM Biosciences, Inc. 14
Testing effectiveness (Phase 2)UnknownNCT05019794What this trial is testingInfigratinib in Subjects With GC or GEJ With FGFR2 Amplification or Other Solid Tumors With Other FGFR AlterationsWho this might be right forGastric CancerGastroesophageal Junction AdenocarcinomaSolid Tumor LianBio LLC 80
Early research (Phase 1)Ended earlyNCT04167137What this trial is testingSafety and Tolerability of SYNB1891 Injection Alone or in Combination With Atezolizumab in Adult ParticipantsWho this might be right forMetastatic Solid NeoplasmLymphoma Synlogic 32
Early research (Phase 1)Ended earlyNCT05631327What this trial is testingA JZP341 Study in Adult Participants With Advanced or Metastatic Solid TumorsWho this might be right forAdvanced Solid TumorMetastatic Solid Tumor Jazz Pharmaceuticals 12
Early research (Phase 1)Not Yet RecruitingNCT06755242What this trial is testingGNC-077 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid TumorsWho this might be right forGastrointestinal TumorsSolid Tumor Sichuan Baili Pharmaceutical Co., Ltd. 20
Early research (Phase 1)Not Yet RecruitingNCT06724042What this trial is testingStudy of ISM5939 in Patients With Advanced and/or Metastatic Solid TumorsWho this might be right forAdvanced Solid TumorMetastatic Solid TumorAdvanced and/or Metastatic Solid Tumors InSilico Medicine Hong Kong Limited 159
Early research (Phase 1)Study completedNCT01875705What this trial is testingA Dose-Escalation Study of GDC-0994 in Patients With Locally Advanced or Metastatic Solid TumorsWho this might be right forSolid Tumor Genentech, Inc. 40
Early research (Phase 1)UnknownNCT01107522What this trial is testingSafety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant GliomasWho this might be right forSolid Tumors, Glioblastoma, Recurrent Malignant Gliomas Tactical Therapeutics, Inc. 100
Not applicableWithdrawnNCT07534813What this trial is testingA Single-Arm Clinical Study of Autologous Tumor-Infiltrating Lymphocyte Injection (GT307) in the Treatment of Metastatic and Recurrent Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors Grit Biotechnology
Early research (Phase 1)Study completedNCT00848718What this trial is testingA Phase I Study of MK-2206 in Combination With Standard Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors (MK-2206-003)Who this might be right forLocally Advanced, Metastatic Solid Tumors Merck Sharp & Dohme LLC 77
Testing effectiveness (Phase 2)Looking for participantsNCT06016062What this trial is testingRC148 As a Single Agent and Combination Therapy in Patients with Locally Advanced Unresectable or Metastatic Malignant Solid TumorsWho this might be right forSolid Tumor RemeGen Co., Ltd. 221